ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Respiratory, thoracic, and mediastinal adverse events associated with ticagrelor: A pharmacovigilance study based on FDA adverse event reporting system.

Yuan Zeng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.